Chemotherapy for Advanced Disease Non-Small Cell Lung Cancer

作者: T. Berghmans , J. P. Sculier

DOI: 10.1007/978-3-642-18698-1_22

关键词:

摘要: There is no consensual definition for advanced disease concerning non-small cell lung cancer (NSCLC). Advanced often considered to be that longer treatable by local thoracic therapy, radiotherapy or surgery. It includes not only metastatic (stage IV), but also some stage III presentations, such as those with pleural pericardial effusions IIIB) where the tumor cannot included in a single irradiation field (corresponding extensive small cancer). should, however, kept mind physicians have broader of “advanced disease” and include patients more-limited cancer; probably because these consider role chest too ancillary prefer use systematic chemotherapy main treatment. A combination nevertheless today standard care unresectable locoregionally disease, despite fact there so far clear evidence improves survival this situation, comparison alone (Sculier et al. 1999b).

参考文章(73)
Jean-Paul Sculier, N. Donnadieu, Marianne Paesmans, CHIMIOTHERAPIE DES CANCERS BRONCHIQUES NON A PETITES CELLULES. META-ANALYSE DE LA LITTERATURE EN FONCTION DE L'EXTENSION DE LA MALADIE Revue Des Maladies Respiratoires. ,vol. 8, pp. 197- 204 ,(1991)
E. Rubesova, J.P. Sculier, A.P. Meert, P. Vermylen, Céline Mascaux, F. Lemaître, M. Paesmans, T. Berghmans, F. Branle, Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment. Anticancer Research. ,vol. 19, pp. 4379- 4390 ,(1999)
Nagahiro Saijo, Tetsu Shinkai, James R. Jett, Hiroyuki Miyaoka, Naoto Keicho, Masanori Sakurai, Hidenobu Takahashi, Yasutsuna Sasaki, Junji Suga, Keigo Tominaga, Akio Hoshi, Tomohide Tamura, Junichi Ishihara, Tetsuro Sano, Kenji Eguchi, Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin. Japanese Journal of Cancer Research. ,vol. 77, pp. 782- 789 ,(1986) , 10.20772/CANCERSCI1985.77.8_782
H Anderson, P Hopwood, R J Stephens, N Thatcher, B Cottier, M Nicholson, R Milroy, T S Maughan, S J Falk, M G Bond, P A Burt, C K Connolly, M B McIllmurray, J Carmichael, Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome British Journal of Cancer. ,vol. 83, pp. 447- 453 ,(2000) , 10.1054/BJOC.2000.1307
J-P Sculier, J-J Lafitte, M Paesmans, J Thiriaux, C G Alexopoulos, J Baumöhl, J Schmerber, G Koumakis, M C Florin, C Zacharias, T Berghmans, P Mommen, V Ninane, J Klastersky, Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. British Journal of Cancer. ,vol. 83, pp. 1128- 1135 ,(2000) , 10.1054/BJOC.2000.1413
J. P. Sculier, T. Berghmans, C. Castaigne, Y. Lalami, S. Luce, C. Sotiriou, P. Vermylen, M. Paesmans, Best supportive care or chemotherapy for stage IV non-small cell lung cancer Springer Berlin Heidelberg. pp. 199- 207 ,(1999) , 10.1007/978-3-642-59824-1_18
M. H. Cullen, L. J. Billingham, C. M. Woodroffe, A. D. Chetiyawardana, N. H. Gower, R. Joshi, D. R. Ferry, R. M. Rudd, S. G. Spiro, J. E. Cook, C. Trask, E. Bessell, C. K. Connolly, J. Tobias, R. L. Souhami, Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life Journal of Clinical Oncology. ,vol. 17, pp. 3188- 3194 ,(1999) , 10.1200/JCO.1999.17.10.3188
Jean Klastersky, Jean-Paul Sculier, Hendrik Lacroix, Gérard Dabouis, Gérard Bureau, P Libert, Michel Richez, Pol Ravez, Guy Vandermoten, Jacques Thiriaux, None, A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. Journal of Clinical Oncology. ,vol. 8, pp. 1556- 1562 ,(1990) , 10.1200/JCO.1990.8.9.1556
A J Wozniak, J J Crowley, S P Balcerzak, G R Weiss, C H Spiridonidis, L H Baker, K S Albain, K Kelly, S A Taylor, D R Gandara, R B Livingston, Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study Journal of Clinical Oncology. ,vol. 16, pp. 2459- 2465 ,(1998) , 10.1200/JCO.1998.16.7.2459
Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb, , Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Journal of Clinical Oncology. ,vol. 18, pp. 2354- 2362 ,(2000) , 10.1200/JCO.2000.18.12.2354